The Home of the Life Sciences Industry

Pictured: AstraZeneca's production plant in Sweden

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need

AstraZeneca reported Monday that adding Lynparza to Imfinzi improved outcomes in mismatch repair proficient endometrial cancer, more than doubling the median duration of response in patients.
Pictured: GSK's headquarters in London/iStock, Wil

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data

New late-stage trial results for GSK’s Jemperli show improved overall and progression-free survival in a broader range of endometrial cancer patients, which could lead to a potential label expansion.